- Trials with a EudraCT protocol (93)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
93 result(s) found for: Cardiac Hypertrophy.
Displaying page 1 of 5.
EudraCT Number: 2008-008479-32 | Sponsor Protocol Number: SR001 | Start Date*: 2009-06-09 | |||||||||||||||||||||
Sponsor Name:University of Dundee | |||||||||||||||||||||||
Full Title: Do xanthine oxidase inhibitors reduce left ventricular hypertrophy and endothelial dysfunction in normotensive patients with chronic stable angina? | |||||||||||||||||||||||
Medical condition: Left ventricular hypertrophy Normotensive Chronic stable angina | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008485-12 | Sponsor Protocol Number: eb/lm/let390/ln950/20038 | Start Date*: 2009-07-01 | ||||||||||||||||
Sponsor Name:University of Dundee | ||||||||||||||||||
Full Title: Do Xanthine Oxidase Inhibitors Regress Left ventricular Hypertrophy in Diabetes? | ||||||||||||||||||
Medical condition: Diabetes Left Ventricular Hypertrophy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002198-37 | Sponsor Protocol Number: ENHVIE | Start Date*: 2016-09-19 | |||||||||||
Sponsor Name:HOSPITAL UNIVERSITARI DE BELLVITGE - IDIBELL | |||||||||||||
Full Title: A single-center, randomized, open-label, 12 months study, with two parallel group to compare the efficacy of everolimus combination + tacrolimus in regression of left ventricular hypertrophy vs tac... | |||||||||||||
Medical condition: Left ventricular hypertrophy in renal transplant patients in the maintenance phase . | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002083-33 | Sponsor Protocol Number: 2012CV15 | Start Date*: 2014-07-22 | ||||||||||||||||
Sponsor Name:University of Dundee/NHS Tayside | ||||||||||||||||||
Full Title: Does Allopurinol regress Left Ventricular Hypertrophy in Patients with Treated Essential Hypertension? | ||||||||||||||||||
Medical condition: Left ventricular hypertrophy in hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000077-39 | Sponsor Protocol Number: RECOGITO_V1.0_2014 | Start Date*: 2014-02-27 | |||||||||||||||||||||
Sponsor Name:Sapienza University of Rome | |||||||||||||||||||||||
Full Title: Study on New Insights in Remodeling of Diabetic Cardiomyopathy: Gender Difference in Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phospho... | |||||||||||||||||||||||
Medical condition: Diabetic Cardiomyopathy, Diabetes Mellitus Type 2, Left Ventricular Hypertrophy | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002376-95 | Sponsor Protocol Number: RRK3535 | Start Date*: 2009-01-05 |
Sponsor Name:University Hospital Birmingham NHS Foundation Trust | ||
Full Title: Myocardial protection with Perhexiline in Left Ventricular Hypertrophy | ||
Medical condition: Patients with left ventricular hypertrophy undergoing aortic valve surgery (with or without coronary artery surgery) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004760-49 | Sponsor Protocol Number: MK001 | Start Date*: 2008-01-02 | ||||||||||||||||
Sponsor Name:University of Dundee | ||||||||||||||||||
Full Title: Do Xanthine Oxidase Inhibitors reduce both Left Ventricular Hypertrophy and Vascular Dysfunction in Cardiovascular patients with Renal Dysfunction? | ||||||||||||||||||
Medical condition: Chronic Kidney Disease Stage 3 Left Ventricular Hypertrophy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-005092-33 | Sponsor Protocol Number: M10-221 | Start Date*: 2008-06-10 | ||||||||||||||||
Sponsor Name:Abbott GmbH & Co. KG | ||||||||||||||||||
Full Title: The PRIMO II Study: Paricalcitol Injection benefits in Renal failure Induced cardiac Morbidity in Subjects with Chronic Kidney Disease Stage 5 | ||||||||||||||||||
Medical condition: Stage 5 Chronic Kidney Disease (CKD) in subjects receiving hemodialysis who have left ventricular hypertrophy (LVH). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) ES (Completed) GB (Prematurely Ended) CZ (Completed) GR (Prematurely Ended) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001689-34 | Sponsor Protocol Number: M10-030 | Start Date*: 2008-04-24 | ||||||||||||||||
Sponsor Name:Abbott GmbH & Co. KG | ||||||||||||||||||
Full Title: The PRIMO Study: Paricalcitol Capsules benefits in Renal failure Induced cardiac Morbidity in Subjects with Chronic Kidney Disease Stage 3B/4. Estudio Primo: Beneficios de Paricalcitol cápsulas sob... | ||||||||||||||||||
Medical condition: Stage 3B/4 chronic kidney disease (CKD) in subjects who have left ventricular hypertrophy (LVH). Insuficiencia renal crónica en estadío 3B/4 en sujetos con hipertrofia ventricular izquierda. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) CZ (Completed) GB (Completed) IT (Completed) DE (Completed) SE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-000686-40 | Sponsor Protocol Number: pulsar | Start Date*: 2023-05-04 | |||||||||||
Sponsor Name:FONDAZIONE TOSCANA GABRIELE MONASTERIO | |||||||||||||
Full Title: Prospective, monocentric, exploratory phase II study for the evaluation of the diagnostic use of the tracer PET (18F) -Flutemetamol (Vizamyl®) in patients with cardiac amyloidosis | |||||||||||||
Medical condition: cardiac amyloidosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002305-38 | Sponsor Protocol Number: 2013CV11 | Start Date*: 2015-01-21 | ||||||||||||||||||||||||||
Sponsor Name:University of Dundee/ NHS Tayside | ||||||||||||||||||||||||||||
Full Title: Does allopurinol reduce right ventricular mass in lung disease associated pulmonary hypertension? | ||||||||||||||||||||||||||||
Medical condition: right ventricular hypertrophy associated with COPD or Interstitial Lung Disease and pulmonary hypertension | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000715-33 | Sponsor Protocol Number: 2015DM07 | Start Date*: 2016-12-19 | ||||||||||||||||
Sponsor Name:University of Dundee & NHS Tayside | ||||||||||||||||||
Full Title: Does Dapaglifozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? | ||||||||||||||||||
Medical condition: Type 2 diabetes and left ventricular hypertrophy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-001005-27 | Sponsor Protocol Number: 1818 | Start Date*: 2011-05-02 | |||||||||||
Sponsor Name:Department of Anaesthesiology, University Hospital of Skejby | |||||||||||||
Full Title: The effect of dobtutamin on postoperative systolic deformation and diastolic function in patients with concentric hypertrophy of the left ventricle | |||||||||||||
Medical condition: Aortic stenosis Diastolic dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000222-35 | Sponsor Protocol Number: 2017-000222-35 | Start Date*: 2017-07-21 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients – a randomized controlled trial | ||
Medical condition: Secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis therapy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001375-11 | Sponsor Protocol Number: not applicable | Start Date*: 2007-05-16 |
Sponsor Name: | ||
Full Title: Effects and health economic aspects of enzyme therapy in children and adults with Pompe disease Long-term follow-up of patients receiving commercially available Myozyme | ||
Medical condition: Pompe disease (glycogen storage disease type II) is a genetic, lysosomal storage disorder with a frequency of 1 in 40.000 newborns. The disease is caused by deficiency of alpha-glucosidase, a lysos... | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002293-54 | Sponsor Protocol Number: Apex01version6 | Start Date*: 2007-11-29 |
Sponsor Name:University of Dundee | ||
Full Title: The APEX Trial: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients with Cardiac Syndrome X | ||
Medical condition: Patients with cardiac syndrome X (typical anginal-like chest pain and normal coronary arteriograms) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003025-10 | Sponsor Protocol Number: VIVID | Start Date*: 2011-11-08 | |||||||||||||||||||||
Sponsor Name:King's College London [...] | |||||||||||||||||||||||
Full Title: Effect of active vitamin-D treatment on left ventricular hypertrophy in patients with type-2 diabetes and stage-3 chronic kidney disease. | |||||||||||||||||||||||
Medical condition: Left ventricular hypertrophy, type 2 diabetes, chronic kidney disease. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002585-33 | Sponsor Protocol Number: PETAL | Start Date*: 2023-01-19 | ||||||||||||||||
Sponsor Name:FONDAZIONE TOSCANA GABRIELE MONASTERIO | ||||||||||||||||||
Full Title: A multi-center phase 3 study of 18F-florbetaben positron emission tomography/computed tomography (PET-CT) | ||||||||||||||||||
Medical condition: cardiac amyloidosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001787-71 | Sponsor Protocol Number: CCB-CRC-07-01 | Start Date*: 2008-02-11 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: The influence of Rimonabant induced cannabinoid receptor blocking on the mass and function of the left ventricle in patients with abdominal adiposity | ||
Medical condition: Adiposity is another risk factor for developing cardiac insufficiency and myocardial hypertrophy. Probably the volume loading of the left ventricle, systemic inflammation, the fatty degeneration of... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-002636-25 | Sponsor Protocol Number: RG_13-013NS | Start Date*: 2013-09-11 |
Sponsor Name:University of Birmingham | ||
Full Title: A Randomised Multicentre Open Label Blinded End Point Trial to Compare the Effects of Spironolactone to Chlortalidone on Left Ventricular Mass and Arterial Stiffness in Stage 3 Chronic Kidney Disease | ||
Medical condition: The condition under investigation is the disease changes that occur in patients with mild kidney disease that cause them to have a high rate of diseases such as heart failure, rhythm disturbance an... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.